| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_726a3d235d237e2ead5f6fc692e40db0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-317
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-351 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 |
| filingDate |
2005-04-26^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-08-25^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efa9834ccc60f6263e43f19a872a3555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3b56166fab64480fcb07b7f953367c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_464e5dc556aaf262751e8ba655eb83c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b19d41ec882119d333969b4bd56f5f1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23d2deeda122d687f09805b18bba9b42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af43c2c6f289563a87760aebe973404a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e044e8357d100fe899803bed5d37091e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3705f99e6d82d5300d3ea28803f1b7f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cf13ff5cab6fdc8004ff360201af118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c662ac9b240cc79c3a7ec3b8dde7f8d8 |
| publicationDate |
2009-08-25^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7579450-B2 |
| titleOfInvention |
Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics |
| abstract |
The invention discloses aptamers capable of binding to Immunoglobulin E (“IgE”) useful as therapeutics in and diagnostics of atopic disease and/or other diseases or disorders in which IgE has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to IgE. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8236570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9085773-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009075342-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8841429-B2 |
| priorityDate |
2004-04-26^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |